Hepatitis B Virus Receptor OATP and Use Thereof

HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

PHARMACEUTICAL COMPOSITION FOR PREVENTING HEPATITIS B VIRUS INFECTION AND USE THEREOF

HBV VACCINES AND METHODS TREATING HBV

COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION

IMMUNOGENIC COMPOSITIONS FOR TREATMENT OF HEPATITIS B

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

MALARIA VACCINE

ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME

HEPATITIS B VACCINES AND USES OF THE SAME

VACCINE DEVELOPMENT PLATFORM USING PLANT-SECRETED NANO-VESICLES FOR DELIVERY OF RECOMBINANT PROTEIN AND mRNA

NOVEL REOVIRUS-BASED VACCINE PLATFORM AND USE THEREOF

ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION

GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND APPLICATIONS THEREOF

MICRONEEDLE FORMULATION, MICRONEEDLE PATCH, AND PREPARATION METHODS THEREOF

ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B

LENTIVIRAL VECTOR, LENTIVIRAL PARTICLE FOR TREATING HEPATITIS B AND ITS PREPARATION METHOD AND APPLICATION THEREOF

MALARIA VACCINE FORMULATIONS

ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES

CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES

HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

SILICON DIOXIDE VACCINE DELIVERY SYSTEM TAKING VIRUS-LIKE PARTICLES AS TEMPLATE, AND CONSTRUCTION METHOD AND APPLICATION OF SILICON DIOXIDE VACCINE DELIVERY SYSTEM

APPLICATION OF ARTIFICIALLY SYNTHESIZED CPG SINGLE-STRANDED DEOXYOLIGONUCLEOTIDE IN VACCINES

Universal vaccine platform

Liquid six combined vaccine composition

MODULATED IMMUNODOMINANCE THERAPY

IDENTIFYING PATIENT POPULATIONS VULNERABLE TO VIRAL INFECTION AND METHODS OF INDUCING HETEROLOGOUS IMMUNITY IN SAME

VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

Methods and compositions for the treatment of hepatitis B infection

BIVALENT DENGUE/HEPATITUS B VACCINES

Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV Core Antigen

IMPROVED THERAPEUTIC COMPOSITION COMPRISING HEPATITIS B ANTIGEN HAVING S, PRE-S1 AND PRE-S2 PROTEIN, ALUMINIUM PHOSPHATE AND INTERFERON-ALPHA AND USE THEREOF FOR TREATMENT OF HEPATITIS B

HBV VACCINE

NUCLEIC ACID VACCINES

Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same

HBV VACCINES AND METHODS TREATING HBV

NANOEMULSION COMPOSITIONS FOR PREVENTING, SUPPRESSING OR ELIMINATING ALLERGIC AND INFLAMMATORY DISEASE

Biological Therapeutics for Infection-Relating Disorders or Conditions

NOVEL VACCINE ADJUVANT

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMBINED FORMULATION, AND COMBINED FORMULATION KIT FOR PREVENTION OR TREATMENT OF CHRONIC HEPATITIS B, EACH COMPRISING, AS ACTIVE INGREDIENT, ORAL ANTIVIRAL AGENT AND THERAPEUTIC VACCINE INCLUDING LIPOPEPTIDE AND POLY(I:C) ADJUVANT

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

Vaccine Boost Methods and Compositions

Pharmaceutical Composition Comprising Hepatitis B Virus-Derived Polypeptide for Prevention or Treatment of Cancer

Hepatitis B vaccines and uses of the same

COMBINATION VACCINE

TREATMENT OF DISEASES RELATED TO HEPATITIS B VIRUS

Antigen Presenting Polypeptide Complexes and Methods of Use Thereof

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

HBV vaccines and methods treating HBV

METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS

Vaccines against hepatitis B virus

USE OF HLA-A*11:01-RESTRICTED HEPATITIS B VIRUS (HBV) PEPTIDES FOR IDENTIFYING HBV-SPECIFIC CD8+ T CELLS

COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HEPATITIS B AND D

Immunogenic compositions for treatment of Hepatitis B

PHARMACEUTICAL COMPOSITION AND USE THEREOF

PHARMACEUTICAL COMPOSITION AND USE THEREOF

STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS

ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME

Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein

METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE

Vaccine delivery method

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

SELF-REPLICATING RNA MOLECULES FOR HEPATITIS B VIRUS (HBV) VACCINES AND USES THEREOF

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAI

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND CAPSID ASSEMBLY MODULATORS BEING SULFONAMIDE DERIVATIVES

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND PYRIDOPYRIMIDINE DERIVATIVES

COBMINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY

HEPATITIS B VIRUS VACCINES

CHIMERIC ANTIGENS FOR TREATING VIRAL INFECTION

NANOPARTICLES FOR USE IN REDIRECTION AGAINST THE TUMOUR OF A NON-TUMOUR SPECIFIC IMMUNE RESPONSE, BASED ON A PRE-EXISTING IMMUNITY

Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND QUINAZOLINE DERIVATIVES

OXALAMIDO-SUBSTITUTED TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND ANTI-PD-1 ANTIBODY

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND PD-L1 INHIBITORS

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND DIHYDROPYRIMIDINE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS

ARENAVIRUS VECTORS FOR HEPATITIS B VIRUS (HBV) VACCINES AND USES THEREOF

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

Composition for treating and/or preventing Hepatitis B virus infection and the use thereof

METHODS TO INCREASE ANTIGENICITY OF MEMBRANE-BOUND POLYPEPTIDES PRODUCED IN PLANTS

PREPARATION OF ZINC ZOLEDRONATE MICRO-NANOPARTICLE ADJUVANT AND USE THEREOF AS VACCINE ADJUVANT

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus

Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same

CONFORMATIONAL EPITOPE OF HEPATITIS B SURFACE ANTIGEN AND ANTIBODY BINDING SPECIFICALLY THERETO

PHARMACEUTICAL PREPARATION FOR TREATING HEPATITIS B, PREPARATION METHOD THEREFOR AND USE THEREOF

VACCINES AGAINST HEPATITIS B VIRUS

RNA REPLICON VACCINES AGAINST HBV

Identifying patient populations vulnerable to viral infection and methods of inducing heterologous immunity in same

Methods and compositions for the treatment of hepatitis B infection

IMMUNOGENIC COMPOSITIONS

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same

Bivalent dengue/hepatitis B vaccines

CHIMERIC ANTIGEN WITH ENHANCED MULTI-IMMUNE FUNCTION THROUGH SPECIFIC BINDING TO TARGET CELL, AND USE THEREOF

Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

BIOACTIVE VITAMIN COMBINATIONS

Universal vaccine platform

PREDICTIVE BIOMARKERS FOR AN IMMUNE RESPONSE

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

Method for efficiently inducing antibody, antibody and detection system for hepatitis virus

Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)

HEPATITIS B VACCINE

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

METHOD OF OBTAINING A POLYEPITOPIC PROTEIN AND POLYEPITOPIC DNA VECTOR

Hepatitis B immunization regimen and compositions

POLYPEPTIDE DRUG AGAINST HEPATITIS B VIRUS PROTEIN

Trimethylglycylglycerin compositions and their use in developing anti-cancer drugs and RNA vaccines

HBV vaccines and methods treating HBV

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

Vaccine delivery method

Hepatitis B vaccines and uses of the same

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

Parapoxvirus vectors

Hepatitis B treatment vaccine base on inactivated whole recombinant Hansenula polymorpha cells which expresses HBsAg and HBcAg

Vaccine adjuvant

Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein

Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen

Methods for inducing an immune response

Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus

Methods for treatment of HBV infection

Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

CTLA-4 antibodies and uses thereof

Nasal hepatitis B vaccine composition and method for producing same

Composition for treating and/or preventing Hepatitis B virus infection and the use thereof

MALARIA VACCINE

Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof

Derivatives And Methods Of Treating Hepatitis B Infections

Virus like particle

Virus-like particles including HBs-L antigen protein for causing immune response against HBV

STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS

Polypeptide carrier for presenting target polypeptide and uses thereof

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

HBV VACCINE

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

Methods for the treatment of subjects having a hepatitis b virus (HBV) infection

Vaccines against Hepatitis B virus

Methods and compositions to increase immune response to vaccines

IMMUNOGENIC COMPOSITION

Fusion proteins and use thereof for preparing vaccines

Universal vaccine platform

IMMUNOTHERAPEUTIC PRODUCT AND MDSC MODULATOR COMBINATION THERAPY

Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

Edible vaccines expressed in yeast for preventing and treating infectious diseases, including hepatitis B, in humans

P14.7 protein and uses thereof as vaccine adjuvant

Immunogenic composition

Biological therapeutics for infection-relating disorders or conditions

Polypeptide carrier for presenting target polypeptide and uses thereof

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

Derivatives and methods of treating hepatitis B infections

Non-activated t cells expressing exogenous virus-specific T cell receptor (TCR)

Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)

Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines

Lentiviral vectors for expression of hepatitis B virus (HBV) antigens

Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

Methods for treating or preventing HBV infection or HBV related diseases

COMBINATION THERAPY WITH CPG TLR9 LIGAND

Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine

Derivatives and methods of treating hepatitis B infections

METHOD OF VACCINATION

Composition for treating HBV infection

Derivatives and methods of treating hepatitis B infections

Means and methods for treating HBV

METHODS TO INCREASE ANTIGENICITY OF MEMBRANE-BOUND POLYPEPTIDES PRODUCED IN PLANTS

Methods and compositions for combination immunotherapy

Anti-hepatitis B virus X protein polypeptide pharmaceutical

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

Vaccines against hepatitis B virus

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Methods and compositions for eliciting an immune response against hepatitis B virus

Injectable vaccines against multiple meningococcal serogroups

Vaccine adjuvant composition comprising inulin particles

Derivatives and methods of treating hepatitis B infections

ANTIBODY-VACCINE ENGINEERED CONSTRUCTS (AVEC)

Hepatitis B therapeutic vaccines

Vaccine formulation, preparation method therefor and use thereof

VACCINES BASED ON HEPATITIS B CORE ANTIGENS

Immunogenic composition

Azepane derivatives and methods of treating hepatitis B infections

In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus-Like Particles

Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus

METHOD FOR PREPARING DENDRITIC CELL LOADED WITH ANTIGEN

Immunostimulating Polyphosphazene Compounds

DNA-peptide combination vaccine

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease

Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B virus infection

METHODS FOR REDUCING LDL-CHOLESTEROL

Modulated immunodominance therapy

Stabilization of Aqueous Compositions of Proteins With Displacement Buffers

HBV epitope reactive exogenous T cell receptor (TCR) and uses thereof

Derivatives and methods of treating hepatitis B infections

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

HBV polymerase mutants

INDUCTION OF IMMUNE RESPONSE

Pharmaceutical compositions comprising CpG oligonucleotides

Methods for inducing an immune response

Derivatives and methods of treating hepatitis B infections

Derivatives and methods of treating hepatitis B infections

Synthetic derivatives of MPL and uses thereof

Methods for inducing an immune response

MODULATED IMMUNODOMINANCE THERAPY

Method of obtaining a polyepitopic protein and polyepitopic DNA vector

Methods and compositions for eliciting an immune response against hepatitis B virus

Immunogenic composition

IMMUNOGEN PLATFORM

Virus like vesicles (VLVS) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection

Vaccines based on hepatitis B core antigens

Method to Enhance an Immune Response of Nucleic Acid Vaccination

Recombinant RNA particles and methods of producing proteins

CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME

MODULATED IMMUNODOMINANCE THERAPY

MODULATED IMMUNODOMINANCE THERAPY

MODULATED IMMUNODOMINANCE THERAPY

MODULATED IMMUNODOMINANCE THERAPY

Vaccines for protection from and treatment of alzheimer's disease

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

ENHANCING BLOOD CELL ESTIMATION

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Lipid nanoparticle vaccine adjuvants and antigen delivery systems

Injectable vaccines against multiple meningococcal serogroups

IMMUNOGENIC COMPOSITIONS FOR INHIBITING HEPATITIS D VIRUS

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

DNA vaccine containing specific epitope of apolipoprotein (a)

CALCIUM FLUORIDE COMPOSITIONS

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

CALCIUM FLUORIDE COMPOSITIONS

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

Adsorption of immunopotentiators to insoluble metal salts

1,2,3-triazole-tethered carbohydrate-di and tri lipidated cysteine conjugates useful as vaccine adjuvants and process for preparation thereof

Mucosal vaccine composition

COMBINATION IMMUNOGENIC COMPOSITIONS

VIRUS-LIKE PARTICLE VACCINES

Derivatives and methods of treating hepatitis B infections

Derivatives and methods of treating hepatitis B infections

Derivatives and methods of treating hepatitis B infections

Pharmaceutical composition for viral immunotherapy and uses thereof

Hepatitis B vaccine

Immunostimulating polyphosphazene compounds

Vaccines against hepatitis B virus

INDUCTION OF IMMUNE RESPONSE

Recombinant polynucleotide and a transgenic carrying the same

Virus-like Particle Vaccines

Nanocapsules of protamine

Treating hepatitis B virus infections by administering receptor associated protein (RAP)

Biological therapeutics for infection-relating disorders or conditions

Rodent hepadnavirus cores with reduced carrier-specific antigenicity

Vaccine combinations

Vaccination strategy

Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain

Azepane derivatives and methods of treating hepatitis B infections

Immunogenic compositions comprising silicified virus and methods of use

Peptide carrier fusion proteins as allergy vaccines

IN VIVO ACTIVATION OF ANTIGEN PRESENTING CELLS FOR ENHANCEMENT OF IMMUNE RESPONSES INDUCED BY VIRUS-LIKE PARTICLES

CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

Azepane derivatives and methods of treating hepatitis B infections

VACCINE

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

Immunomodulating compositions and uses therefor

Method of storing a vaccine containing an aluminum adjuvant

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

Immunostimulating Polyphosphazene Compounds

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

Azepane derivatives and methods of treating hepatitis B infections

Yeast-based therapeutic for chronic hepatitis B infection

Immunostimulatory oligonucleotides

Stabilization of Aqueous Compositions of Proteins with Displacement Buffers

Immunogenic composition

VACCINES COMPRISING AN IMMUNOSTIMULATORY PEPTIDE AND AN IMMUNOSTIMULATORY OLIGODEOXYNUCLEIC ACID MOLECULE

Facilitator-DNA combination vaccine

Method to enhance an immune response of nucleic acid vaccination

Laser-based vaccine adjuvants

SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF

VACCINE

VACCINE COMPRISING A TLR-5 AGONIST AS ADJUVANT FOR USE IN CUTANEOUS IMMUNISATION

Vaccine adjuvant composition comprising inulin particles

Immunostimulating Polyphosphazene Compounds

MANUFACTURE OF VACCINES THAT CONTAIN BOTH HEPATITIS B VIRUS SURFACE ANTIGEN AND SURFACTANT

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Hypo- and hyper-acetylated meningococcal capsular saccharides

Vaccine composition

DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES

Methods to increase antigenicity of membrane-bound polypeptides produced in plants

Vaccines for protection from and treatment of alzheimer's disease

Peptide carrier fusion proteins as allergy vaccines

Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines

NON-SELF T-CELL EPITOPE FUSED TO AN ANTIBODY THAT RECOGNISES A TUMOUR-SPECIFIC CELL-SURFACE RECEPTOR AND USES THEREOF

Methods of improving vaccine immunogenicity

Chimeric immunomodulatory compounds and methods of using the same-IV

METHOD FOR PREPARING HBV VACCINE COMPRISING ALUMINUM ADJUVANT

Epitope and its use of hepatitis B virus surface antigen